Efficacy and Safety of Ciprofloxacin XR 1000 mg Once Daily Versus Ciprofloxacin 500 mg Twice Daily in the Treatment of Complicated Urinary Tract infections

REFERENCES

• Bacheller CD, Bernstein JM. Urinary tract infections. Med Clin North Am 1997; 81 (3): 719–30.
   PubMed Web of Science ®Google Scholar
• Hooton TM, Samm WE. Diagnosis and treatment of un-complicated urinary tract infection. Infect Dis Clin North Am 1997; 11 (3): 551–81.
   PubMed Web of Science ®Google Scholar
• Ronald AR, Harding GK. Complicated urinary tract infections. Infect Dis Clin North Am 1997; 11 (3): 583–92.
   PubMed Web of Science ®Google Scholar
• Sobel JD, Kaye D. Urinary Tract Infections. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Dooglas and Bennett's Principles and practice of Infectious Disease, 5th edition edn. Philadeplhia, USA: Churchill Livingstone 2000: 773-805.
   Google Scholar
• Nicolle LE. Complicated Urinary Infection Including Post-surgical and Catheterrelated Infections. In: Cohen J, Armstrong D, editors. Infectious Diseases. London, UK: Mosby 2000; 60.1-60.8.
   Google Scholar
• Ludwig E. Bacteriuria in women with diabetes mellitus. In-fect Urol 2000; 13:s3–s6.
   Google Scholar
• Carson C, Naber KG. Role of fluoroquinolones in the treat-ment of serious bacterial urinary tract infections. Drug 2004; 64 (12) :1359–73.
   PubMed Web of Science ®Google Scholar
• Gilbert DN. Urinary tract infectious in patient with chronic renal insufficiency. Clin J Am Soc Nephrol 2006; 1: 327–331.
   PubMed Web of Science ®Google Scholar
• Saltzstein D, Wachs B, Perroncel R, Benson A, Herrington J, Haverstock D et al. Complicated urinary tract infections with extended release ciprofloxacin with emphasis on Pseudomonas aeruginosa. J Chemother 2007; 19 (6): 694-702.
   Google Scholar
• UrbAnek K, Kolár M, Strojil J, Koukalova D, Cekanova L, Hejnar P. Utilization of fluoroquinolones and Escherichia coil resistance in urinary tract infection: inpatients and outpatients. Pharmacoepidem Drug Safety 2005; 14: 741–745.
   PubMed Web of Science ®Google Scholar
• Naber KG, di Silverio F, Geddes A et al. Comparative efficacy of sparfloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection. J Antimicrob Chemother 1996; 37: 135–44.
   Google Scholar
• Krcmery S, Naber KG. Ciprofloxacin once versus twice daily in the treatment of complicated urinary tract infections. Ger-man Ciprofloxacin UTI Study Group. Int J Antimicrob Agents 1999; 11 (2): 133–8.
   PubMed Web of Science ®Google Scholar
• Raz R, Naber KG, Raizenberg C Rohana Y, Unamba-Oparah I, Korfman G et al Ciprofloxacin 250 mg twice daily ver-sus ofloxacin 200mg twice daily in the treatment of complicated urinary tract infections in women. Eur J Clin Microbiol Infect Dis 2000; 19 (5): 327–31.
   PubMed Web of Science ®Google Scholar
• Talan DA, Stamm WE, Hooton TM Moran GJ, Burke T, Iravani A et al. Comparison of ciprofloxacin (7days) and trimetho-prim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial. JAMA 2000; 283: 1583–90.
   Google Scholar
• Coc CE, Marbury TC, Pittman WG, Auerbach SM, Fox BC, Yang JY. A randomized, double-blind, multicenter compar-ison of gatifloxacin versus ciprofloxacin in the treatment of com-plicated urinary tract infection and pyelonephritis. Clin Ther 2002; 24: 223–36.
   PubMed Web of Science ®Google Scholar
• Alexander CJ, Goldstein EJC, Citron DM, De Cherne AH. Review of the comparative in vitro susceptibilities of lower female genital tract pathogens to older and newer fluoro-quinolones. Anaerobe 2000; 6: 313–323
   Web of Science ®Google Scholar
• AypaK C, Althunsoy A, Duzgun N. Empiric antibiotic ther-apy in acute uncomplicated urinary tract infections and fluoro-quinolone resistance: a prospective observational study. Ann Clin Microbiol Antimicrob 2009; 24: 8–27.
   Google Scholar
• Turnidge J, Bell J, Biedenbach DJ, Jones RN. Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: Report from the SENTRY Antimicrobial Surveillance Program, 1998-1999. Int J Antimicrob Agents 2002; 20: 10–17.
   PubMed Web of Science ®Google Scholar
• Jones RN, Kugler KC, Pfaller MA, Winokur PL. Charac-teristics of pathogens causing urinary tract infections in hospitals in North America: Results from the SENTRY Antimicrobial Sur-veillance Program, 1997. Diagn Microb Infect Dis1999; 35: 55–63.
   PubMed Web of Science ®Google Scholar
• Daza R, Gutierrez J, Piedrola G. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections. Int J Antimicrob Agents 2001; 18: 211–215.
   PubMed Web of Science ®Google Scholar
• Farrell DJ, Morrissey I, De Rubeis D, Robbins M, Felm-ingham D. A UK multicentre study of the antimicrobial suscepti-bility of bacterial pathogens causing urinary tract infection. J Infect 2003; 46: 94–100.
   PubMed Web of Science ®Google Scholar
• Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: The ECO-SENS project. J Antimicrob Chemother 2003; 51: 69–76.
   PubMed Web of Science ®Google Scholar
• Gales AC, Sader HS, Jones RN. The Sentry Participants Group (Latin America). Urinary tract infection trends in Latin American hospitals: Report from the SENTRY antimicrobial sur-veillance program (1997-2000). Diagn Microb Infect Dis 2002; 44: 289–299.
   Google Scholar
• Gordon KA, Jones RN, SENTRYParticipant Groups (Eu-rope, LA, North America). Susceptibility patterns of orally ad-ministered antimicrobial among urinary tract infection pathogens from hospitalized patients in North America: Comparison report to Europe and Latin America. Results from the SENTRY An-timicrobial Surveillance Program (2000). Diagn Microb Infect Dis 2003; 45: 295-301.
   Google Scholar
• Colomina Aviles J, Fuentes Luri S, Cascales Ramos P, Pascual Perez R, Cabo Moya C. Infección urinaria y resistencia bacteriana en urocultivos de pacientes ambulatorios. An Med In-tern 2000; 17: 506–507.
   Google Scholar
• Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm DF. Trends in antimicrobial resistance among urinary tract in-fection isolates of E. coil from female outpatients in the United States. Antimicrob Agents Chemother 2002; 46: 2540–2545.
   PubMed Web of Science ®Google Scholar
• Mathai D, Jones RN, Pfaller MA. Epidemiology and frequency of resistance among pathogens causing urinary tract in-fection in 1,510 hospitalized patients: A report from the SENTRY Antimicrobial Surveillance Program (North America). Diagn Microbiol Infect Dis 2001; 40: 129–136.
   PubMed Web of Science ®Google Scholar
• Fourcroy JL, Berner B, Chiang YK, Cramer M, Rowe L, Shore N. Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncompli-cated urinary tract infection in women. Antimicrob. Agents Chemother 2005; 49: 4137–4143.
   PubMed Web of Science ®Google Scholar
• Gagliotti G, Buttazzi R, Sforza S, Moro ML, Emilia-Ro-magna Antibiotic Resistance Study Group. Resistance to fluoro-quinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coil. J Infect 2008; 57 (3): 179-84.
   Google Scholar
• Talan DA, Klimberg LW, Nicolle LE. Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis. J Urol 2004; 171: 734–9.
   PubMed Web of Science ®Google Scholar
• Hickerson AD, Carson CC. The treatment of urinary tract infections and use of ciprofloxacin extended release. Expert Opin Investig Drugs 2006; 15: 519–32.
   PubMed Web of Science ®Google Scholar
• Schuck EL, Dalhoff A, Stass H, Derendorf H. Pharmaco-kinetic/ pharmacodynamic(PK/F'D) evaluation of a once daily treatment using ciprofloxacin in an extended release dosage form. Infection. 2005;33 Suppl 2: 22–8.
   PubMed Web of Science ®Google Scholar
• Hickerson AD, Carson CC. The treatment of urinary tract infections and use of ciprofloxacin extended release. Expert Opin Investig Drugs. 2006; 15 (5): 519–32.
   PubMed Web of Science ®Google Scholar